title: [Toxocara canis encephalitis: case report].
authors.forename: R
authors.initials: R
authors.lastname: Mrissa
authors.forename: R
authors.initials: R
authors.lastname: Battikh
authors.forename: N
authors.initials: N
authors.lastname: Ben Abdelhafidh
authors.forename: B
authors.initials: B
authors.lastname: Jemli
authors.forename: O
authors.initials: O
authors.lastname: Azzouz
authors.forename: J
authors.initials: J
authors.lastname: Zaouali
authors.forename: B
authors.initials: B
authors.lastname: Louzir
authors.forename: F
authors.initials: F
authors.lastname: M'sadek
authors.forename: N
authors.initials: N
authors.lastname: Ben Abdallah
authors.forename: S
authors.initials: S
authors.lastname: Gargouri
authors.forename: M
authors.initials: M
authors.lastname: Yedeas
authors.forename: S
authors.initials: S
authors.lastname: Othmani
mesh_terms: D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D017166:Toxocara canis; D014120:Toxocariasis / Q000175:diagnosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics; D000893:Anti-Inflammatory Agents; D015766:Albendazole; D011241:Prednisone